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Short Communication
HIV Type 1 Subtype C Variants Transmitted Through
the Bottleneck of Breastfeeding Are Sensitive to New
Generation Broadly Neutralizing Antibodies Directed
Against Quaternary and CD4-Binding Site Epitopes
Elizabeth S. Russell,1,* Suany Ojeda,1 Genevieve G. Fouda,2 Steven R. Meshnick,3 David Montefiori,2
Sallie R. Permar,2 and Ronald Swanstrom1,4
Abstract
Mother-to-child transmission of HIV-1 subtype C can occur in utero, intrapartum, or via breast milk exposure.
While not well understood, there are putative differences in the mechanisms involved with the distinct routes of
vertical HIV transmission. Here, we address the question of whether specific viral characteristics are common to
variants transmitted through breastfeeding that may facilitate evasion of innate or adaptive immune responses.
We amplified the envelope gene (env) from the plasma of six infants during acute infection who were infected
with HIV-1 subtype C through breastfeeding, and from three available matched maternal samples. We se-
quenced the full-length env genes in these subjects revealing heterogeneous viral populations in the mothers and
homogeneous populations in the infants. In five infants, the viral population arose from a single variant, while
two variants were detected in the remaining infant. Infant env sequences had fewer N-linked glycosylation sites
and shorter sequences than those of the available matched maternal samples. Though the small size of the study
precluded our ability to test statistical significance, these results are consistent with selection for virus with
shorter variable loops and fewer glycosylation sites during transmission of HIV-1 subtype C in other settings.
Transmitted envs were resistant to neutralization by antibodies 2G12 and 2F5, but were generally sensitive to the
more broadly neutralizing PG9, PG16, and VRC01, indicating that this new generation of broadly neutralizing
monoclonal antibodies could be efficacious in passive immunization strategies.
Transmission of human immunodeficiency virus-1(HIV-1) through breastfeeding (BF) makes up one-third
to one-half of all mother-to-child transmission events.1 The
mechanism(s) of transmission, however, are poorly under-
stood. The oral cavity and gastrointestinal tract of breastfed
infants are exposed daily to both cell-free and cell-associated
HIV-1,2–4 yet the majority of infants remain uninfected even if
neither mother nor baby receive antiretroviral prophylaxis.5
This inefficiency of transmission indicates that anatomical,
innate, and/or adaptive mechanisms of protection are able to
prevent transmission to a great extent.6–11 Maternal anti-
bodies could prevent infection either through direct binding
of virus in the breast milk, or by their systemic and mucosal
presence in the infant. This passive maternal immunity in the
infant increases in concentration during the last trimester of
gestation, and continues to pass into the infant through
breastfeeding.
Studies of in utero and intrapartum transmission have
shown a universal bottleneck in genetic diversity from mother
to child, as well as differences in the characteristics of trans-
mitted virus for in utero versus intrapartum transmission.12,13
Data are very limited for breastfeeding pairs, but one study of
three breast milk transmission events found a similar bottle-
neck for HIV-1 subtype A.14 We previously demonstrated that
the viral population found in infants infected intrapartum
tended to be more heterogeneous than populations from
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infants infected in utero, and that viruses from infants infected
intrapartum tended to have shorter variable loops and fewer
glycosylation sites than the parent viral population.13,15
Others had similar findings for infants mostly infected
intrapartum, though they only found differences in
glycosylation sites and not variable loop lengths.16
In this article, we present data on viral sequences from three
mother–child pairs plus three additional infants where the
infant became HIV DNA positive between 6 and 12 weeks
postpartum through exposure to breast milk, with the goal of
exploring whether known selective pressures influence this
route of mother-to-child transmission. Participant plasma
samples were collected from the Malaria and HIV-1 in Preg-
nancy (MHP) prospective cohort.17–20 The MHP study was
approved by the Malawi College of Medicine Research
Committee and the Institutional Review Board at the Uni-
versity of North Carolina at Chapel Hill. Informed consent
was obtained from all mothers. Women and their newborn
infants received single-dose nevirapine according to the HIV-
NET 012 protocol20 and breastfeeding was initiated. Plasma and
cell pellets were isolated from blood collected from the mothers
at labor-ward admission, and blood was collected via heel-sticks
from the infants at three time points: within 48 h of birth, at 6
weeks, and at 12 weeks of age. Infants who were HIV-1 DNA
negative by real-time polymerase chain reaction (PCR)21 at 0
and 6 weeks, then positive at 12 weeks were classified as in-
fected postpartum through breastfeeding (BF). Viral RNA and
cell-associated DNA were isolated and amplified using single-
genome env gene amplification, as has been described previ-
ously,15,22 to ensure that most amplifications were initiated with
a single template without artifactual recombination during PCR
between multiple template sequences. The HIV-1 env DNA
single genome amplification protocol was the same as the RNA
protocol following reverse transcription (GenBank accession
numbers JN983803–JN983805).
Sequences were aligned using the L-INS-I method in
MAFFT version 5.8.23 A maximum likelihood phylogenetic
tree was constructed with PHYML24 using the general time
reversible plus gamma (a *0.25 for each tree) evolutionary
model chosen by FindModel (hiv.lanl.gov) with four rate
substitution categories. Trees were resampled 100 times and
bootstrap values greater than 70 were considered significant.
In a tree including all sequences, each infant or mother–infant
pair clustered together as a distinct clade (Supplementary
Fig. S1; Supplementary Data are available online at www
.liebertpub.com/aid). Cell-free (viral RNA) and cell-associated
(viral DNA) viral populations were highly similar in the in-
fant, as expected in acute infection, and allowed for analysis of
viral sequences from blood plasma or cell pellets from BF-
infected infants as available (Fig. 1 and Supplementary Table
S1). Five of six infants appeared to be infected with a single
variant, while in the remaining infant (942) a second minor
variant was amplified from two distinct reactions. In the three
mother–infant paired samples, maternal populations were
more heterogeneous than the infant populations, demon-
strating a bottleneck in viral diversity during HIV-1 subtype C
BF transmission (Fig. 1 and Supplementary Table S1). Within-
participant sequence diversity was conducted using the Ki-
mura two-parameter method in MEGA4.25,26 Infant viral env
populations were more homogeneous than maternal popu-
lations, and the infant populations were highly similar in their
low diversity, with £ 0.2% diversity in infants with single
variants. In addition, using the Poisson-Fitter tool,27 sequence
populations from all infants had a Poisson distribution of
mutations and a phylogeny that coalesced to an inferred
consensus sequence representing a virus present at or near the
time of HIV-1 transmission (data not shown) and predicted
time since most recent common ancestor (MRCA) was also
less than 12 weeks for all (84 days), supporting transmission
during breastfeeding. For infant 942 the minor variant and
recombinant sequences were excluded in this analysis. Thus,
we infer that in five of six BF mother–infant pairs a single
variant was transmitted or established the infant infection,
while in the sixth infant a second minor variant was identified.
In maternal–infant pair 942 there is evidence for the
transmission/replication of two maternal variants in the in-
fant (Fig. 1). Using a Highlighter plot (hiv.lanl.gov) (data not
shown), we found 41/49 infant sequences were nearly iden-
tical with mutations following a model of random evolution.
Two infant sequences were distinct, indicating a second
transmitted variant; the final viral RNA infant sequence was a
recombinant of the two sequences. Because we used single-
genome amplification, a method with a very low probability
of recombination during amplification, we propose recombi-
nation within the infant as the likely source. Analysis with
Poisson-Fitter found all 942 infant sequences had a mean
hamming distance (HD) of 3.4 and MRCA of 64 days. Yet
upon removal of the two minor variant sequences the mean
HD decreased to 1.6 and the MRCA to 31 days, demonstrating
their influence in the analysis. Both sequences could have
been transmitted to the infant during the same transmission
event, or through two separate events. Our data are similar to
those reported in cohorts of heterosexual transmission, where
the likelihood of transmission of multiple variants is around
20%, and overall suggest that the low probability of transmis-
sion for any given exposure generally results in the transmis-
sion of a single variant when an infection does occur.12,28–34
We next compared the number of putative N-linked gly-
cosylation sites (N-glycosite program, hiv.lanl.gov) and se-
quence length between mother and infant viral populations.
Fewer glycosylation sites and shorter full-length env se-
quences were seen in infants compared to their mothers over
env in all three transmission pairs (Supplementary Table S1).
These differences were not common to a particular variable or
constant region (data not shown). The small sample size of
this study does not allow testing for statistical significance of
these differences between matched pairs, but the differences
are of a magnitude similar to the significant results from our
previous work with intrapartum transmission pairs and other
studies of undetermined intrapartum (IP)/BF transmis-
sion.16,35 A larger sample size would be needed to confirm an
association.
The presence of multiple variants in infant 942 could rep-
resent separate transmission events, or multiple variants si-
multaneously transmitted in a single event. It is worth noting
that the two variants clustered on the same tree branch
compared to the more diverse maternal viral population (Fig.
1). This phenomenon was also seen in an IP transmission pair
for HIV-1 subtype B.36 This similarity between variants could
be stochastic or it could suggest selection for certain charac-
teristics (in breast milk, during transmission, or through se-
lective amplification in the infant).37–39 Other studies have
presented conflicting results testing the hypothesis that se-
lection is influenced by neutralizing antibodies, and
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transmitted variants are generally resistant to neutraliza-
tion.14,36,39 Thus, we investigated the neutralizing antibody
resistance profile of these subtype C infant viral variants
transmitted through breast milk for comparison.
The consensus (or transmitted/founder) infant env gene (or
a close match with 1 nt change for 942 and 1266) from each
infant was cloned as previously described15 (Fig. 1). Viruses
were assayed as Env pseudotyped viruses for sensitivity to
soluble CD4 (sCD4) and to a panel of monoclonal antibodies
[2G12, 2F5, 4E10, IgG1b12, PG9, PG16 (gifts of Dennis Bur-
ton), VRC01 (gift of John Mascola), CH31 (gift of Bart
Haynes)], and subtype C HIVIG. Titers are reported as the
antibody concentration or reciprocal serum dilution with a
50% reduction in relative luminescence units, as previously
described.40 Values were interpolated using 5 parameter
curve-fitting. As expected for subtype C virus, no pseudo-
typed infant virus was sensitive to monoclonal antibodies
2G12 or 2F5 up to a concentration of 25 lg/ml.40 Five of the six
FIG. 1. Maximum likelihood phylogenetic trees for (A) unmatched infant cell-associated HIV DNA env sequences and
(B–D) matched mother–infant pairs. (B–D) Filled triangles indicate maternal env RNA HIV sequences, open circles infant HIV
env RNA sequences, and filled circles infant HIV env DNA sequences. Arrows point to cloned env genes. Outgroups have
been cropped for space.
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pseudotyped infant viruses were sensitive to 4E10 and PG16
within this range, while 1677 was resistant to both. All infant
viruses were sensitive to PG9, and all but 942 were sensitive to
VRC01 and CH31.
The panel of neutralizing antibodies used in this study
represents both the previous generation of monoclonal an-
tibodies (mAbs) with potent neutralization of subtype B
HIV-1, yet importantly also includes more recently identified
mAbs with extensive breadth even against the previously
‘‘difficult to neutralize’’ HIV-1 subtype C. The resistance
profiles found for the infant clones described here are similar
to other studies of newly infected infant viral variants of
several HIV-1 subtypes.14,16,36,41 While we saw little neu-
tralization to 1b12 (Table 1) compared to some other studies
where 50% or more of viruses were sensitive,41,42 the results
were similar to our previous study of uncultured Envelope
pseudotypes from virus newly transmitted from mother to
child.15 Only one study of three infants infected through
breast milk39 also analyzed sensitivity to the recently iden-
tified broadly neutralizing PG9 and PG16 antibodies.43,44
Similarly, all six infant clones tested herein were sensitive to
PG9, and all but one were sensitive to PG16, which have a
conformational epitope in the V1/V2 region. In addition, the
sensitivity of these variants to the CD4 binding-site anti-
bodies VRC01 and CH31 further demonstrates that trans-
mitted infant subtype C viruses are not inherently resistant
to neutralization and that recently transmitted viruses may
have neutralizing epitopes in common among all prevalent
subtypes. These antibodies clearly have enhanced breadth
that includes neutralization of subtype C, and for this reason
may represent a useful tool for passive immunization in
regions where clade C HIV-1 is prevalent.41 These data in
particular support the CD4 binding site as a promising tar-
get for infant vaccine design.
In summary, we analyzed env sequence data from six in-
fants infected with HIV-1 subtype C through breastfeeding,
including three transmission pairs. There was a strong genetic
bottleneck during transmission, and more than one variant
was transmitted in only one of six infants. Viral envelopes
were generally resistant to the monoclonal neutralizing anti-
bodies 2G12 and 2F5, yet were generally sensitive to 4E10 and
the more recently identified antibodies PG9, PG16, VRC01,
and CH31. The neutralizing sensitivity of these postnatally
transmitted virus variants supports the use of the new gen-
eration of broadly neutralizing antibodies directed against
quaternary V1/V2 epitopes or the CD4 binding site for infant
passive immunization strategies, and also implicates these
epitopes in infant HIV vaccine design.
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